Esta traducción se está preparando. Mientras tanto, mostramos temporalmente la versión original en inglés.
Regulación y derecho · 27/9/20231 min de lectura
Prospective Grant of an Exclusive Patent License: Development and Commercialization of Engineered T Cell Therapies for the Treatment of Cancer
Traducción automática local · Idioma original de la fuente
Resumen
The National Cancer Institute, an institute of the National Institutes of Health, Department of Health and Human Services, is contemplating the grant of an Exclusive Patent License to practice the inventions embodied in the Patents and Patent Applications listed in the SUPPLEMENTARY INFORMATION section of this notice to Moonlight Bio, Inc. ("Moonlight"), headquartered in Seattle, WA.
Idioma original de la fuente: Federal Register — All DocumentsAbrir el comunicado original →